Secretary Kennedy: "We have 4.2% of the world’s population. We take 13% of the pharmaceutical drugs. We spend 80% of the biotechnology research in our country and we provide 75% of the profits to the pharmaceutical industry. This is a rip off that has irked @POTUS for 20 years."

Will be an exciting JPM week. Will be co chairing the Inaugural USA Saudi Biotech Alliance with senior decision makers flying in to an exciting all day event. @ImmunityBio, Nantworks reveal, biotechs, and bankers. More to come.

It’s great to see progress at Cellenkos with much needed innovative Tx. In 3/2025, their CEO joined me on #HealthcareUnfiltered to discuss the journey and platform - check out what it takes to build something from the ground up. podcasts.apple.com/us/podcas… prnewswire.com/news-releases…

Thank you for sharing. IL-15 (Anktiva) is the secret key to activating NK and T cells (lymphocytes). Glad your oncology center is seeing the effects on patients when the immune system is activated.

Dr. Patrick Soon-Shiong on Immunotherapy & Cancer Cure - Los Angeles Times latimes.com/b2b/business-vis…

If our healthcare system has recognized that lymphopenia is a disease by approving a BILLING CODE for lymphopenia, then what is the logic behind not enabling the doctor to then correct the condition when a treatment exists? Especially since there is no longer any mystery that lymphopenia reduces survival…whether from cancer, infection or sepsis. I wake up everyday trying to figure out the reason ! Lives are at stake.

A billionaire oncologist just went on national television and said the words millions have been waiting to hear publicly. Dr. Patrick Soon-Shiong – the surgeon who invented the nanoparticle chemotherapy Abraxane, sold companies for billions, and now owns the LA Times – appeared on NewsNation’s primetime special “Killing Cancer: The Power Within” with Chris Cuomo. He looked straight into the camera and said: “When you actually biopsy these new aggressive tumors, we are finding spike protein inside the tumors.” Chris Cuomo: “From Covid?” Dr. Soon-Shiong: “From Covid.” He then described patients he’s seeing in 2025: - 10- and 11-year-old children with colon cancer - A 13-year-old who died in his clinic from pancreatic cancer - A close friend whose thymoma was dormant for 30 years – got Covid/vaccinated – now widespread metastasis - Jim Johnson: beat HPV-related throat cancer, 7 years clean, got vaccinated, then became the first known case of HPV spreading to the liver. Doctors “had no idea why.” This is not a podcast guest. This is the man whose new FDA-approved drug Anktiva is training the body’s own natural killer cells to destroy bladder, lung, pancreatic, and other cancers – with patients in full remission who were sent home to die. Watch this 59-second exchange from the NewsNation special. Decide for yourself. Questions deserve answers. Why the explosion of rare and pediatric cancers since 2020? What role does persistent spike protein play? And why are we finally on the verge of making chemotherapy obsolete with therapies like Anktiva? No hysteria. Just a world-class doctor describing biopsies and patients he’s treating right now. If this matters to you or someone you love, share it. Tag a cancer fighter. The truth doesn’t need shouting – it just needs daylight.

A potential game changer in #cancer treatment just aired on national television. Dr. Patrick Soon-Shiong (the billionaire surgeon who invented Abraxane & owns the LA Times) appeared on NewsNation with Chris Cuomo & laid out compelling evidence that his IL-15 super-agonist drug, Anktiva, is producing complete remissions in patients who were literally weeks from death, patients who had already failed chemotherapy, radiation & every checkpoint inhibitor. He brought one of those patients on the show live. The man was bedridden & given days to live. After Anktiva, he walked onto the set unaided. Soon-Shiong’s exact words: • “This passes grandma’s test. If your grandmother saw a man at death’s door suddenly sitting here on television, she’d say ‘that’s a miracle.’” • “We are seeing patients with end stage cancer come back to life.” • “Every cancer patient deserves a doctor who still has hope.” Then former CDC Director Dr. Robert Redfield joined the segment & went further: • “Patrick is onto something profound.” • “The FDA needs to accelerate this now.” • “We have to abandon the old “destroy the patient to kill the cancer model.” • “Chemo & radiation wipe out the immune system. IL-15 rebuilds & supercharges it.” • “When you personally watch 10 people who were supposed to die get up & live, that means something.” Redfield also revealed he was diagnosed with cancer earlier this year & refused chemotherapy & radiation entirely because he believes the future is immune activation, not immune destruction. This wasn’t hype, it was two of the most credentialed men in American medicine openly declaring that the decades old war on cancer playbook may finally be obsolete & that a new immune based paradigm built around natural killer cells & IL-15 could be the breakthrough millions have prayed for. The drug is already FDA approved for one form of bladder cancer & available off label through expanded access. The question now is how fast can regulators & the medical establishment move? If even a fraction of what aired is confirmed in larger trials, this will go down as one of the biggest medical stories of the decade.

Billionaire @drpatrick developed a new cancer therapy, Anktiva, that does not require patients to go through chemotherapy. But how does it work? newsnationnow.com/health/ank…

Thank you Chris and NewsNation for giving our patients their voices. It is a honor and privilege to do what we do with our amazing team of scientists, doctors and nurses.

Welcome back! Special Welcome to our class of 2026! Have A Great Year SENIORS! #GoOxbridge

Support Ending stigmas on women’s bodies. every.org/mantra-4-change/f/… via @everydotorg

The partnership will pave the way for expanding studies of treating patients with ALS and cardiovascular diseases with Dr. Parmar's therapy, which has been evaluated in dozens of human patients to date and shown to be safe and effective: tx.ag/TAMUS052225

A new cell therapy invented by @TAMUmedicine associate professor Dr. Simrit Parmar that shows strong promise in treating ALS and other diseases has attracted a major investment and partnership announced today with the leading medical center in Riyadh, Saudi Arabia.

Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory C... prn.to/3YXBIen

Cellenkos Announces US FDA Orphan Drug Designation Granted to CK0801 (Allogeneic Cord Blood derived T regulatory C... prn.to/4cGzshm

The amazing inspiring Dr. Parmar (⁦@LurieCancer⁩ alum) on her start-up - how did it all start? And how challenging to get it off the ground in the cellular therapy space? Just a fascinating journey - you’ll listen to this one twice. Clip and link: podcasts.apple.com/us/podcas…

Cutting-edge cell therapy is here! Dr. Simrit Parmar joins #CellAndGenePodcast to talk about Cellenkos’ breakthrough in umbilical cord blood-derived Treg therapies. Learn about the latest CK0804 trial & what’s coming in 2025! @ErinHarris_1 @_CellandGene @spa718